Chemical modulation of airway epithelial permeability.

por Boucher, R C
Publicado 1980

496: Reduced susceptibility of mice with CF-like lung disease to SARS-CoV-2 infection

por Hawkins, P., Okuda, K., Leist, S., Schafër, A., Gilmore, R., Volmer, A., Chua, M., Livraghi-Butrico, A., O’Neal, W., Baric, R., Boucher, R., Pickles, R.
Publicado 2021

The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies

por Ward, J.D., Cornaby, C., Kato, T., Gilmore, R.C., Bunch, D., Miller, M.B., Boucher, R.C., Schmitz, J.L., Askin, F.A., Scanga, L.R.
Publicado 2022

485 Chronic sequelae of SARS-CoV-2 in the Scnn1b-Tg mouse model of cystic fibrosis lung disease

por Hawkins, P., Anderson, W., Leist, S., Okuda, K., Schaefer, A., Gilmore, R., Chua, M., Volmer, A., Dang, H., Pickles, R., Livraghi-Butrico, A., Baric, R., O'Neal, W., Boucher, R.
Publicado 2022

515: Pathways balancing SARS-COV-2 infectivity and disease severity in CF

por Nakano, S., Okuda, K., Edwards, C., Dang, H., Asakura, T., Kato, T., Mikami, Y., Chen, G., Sun, L., Hawkins, P., Gilmore, R., Morton, L., Ribeiro, C., Pickles, R., Randell, S., O’Neal, W., Baric, R., Boucher, R.
Publicado 2021